Unicycive Therapeutics, Inc (UNCY) Misses Q1 EPS by 54c

Unicycive Therapeutics, Inc (NASDAQ: UNCY) reported Q1 EPS of ($0.54).

For earnings history and earnings-related data on Unicycive Therapeutics, Inc (UNCY) click here.

You May Also Be Interested In

• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• Walhalla Gold names Lisa Gibbons to its board of directors
• Uxin Limited (UXIN) Reports Q3 EPS of $0.00